LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "obesity drugs" as a keyword



Benefit-Risk Assessment of Obesity Drugs: Focus on Glucagon-like Peptide-1 Receptor Agonists

Sign Up to like & get
recommendations! Published in 2019 at "Drug Safety"

DOI: 10.1007/s40264-019-00812-7

Abstract: The prevalence of obesity and related comorbidities is increasing worldwide. Furthermore, clinically meaningful body weight losses has proven difficult to achieve and especially to maintain through sustained lifestyle change in the form of diet and… read more here.

Keywords: weight loss; obesity drugs; benefit risk; receptor ... See more keywords

Pharmacotherapy in obesity: a systematic review and meta-analysis of randomized controlled trials of anti-obesity drugs

Sign Up to like & get
recommendations! Published in 2019 at "Expert Review of Clinical Pharmacology"

DOI: 10.1080/17512433.2020.1698291

Abstract: ABSTRACT Introduction: Obesity poses a significant increase in morbidity and mortality and thus five anti-obesity drugs have been approved currently by US FDA. Several phase 3 trials have shown a significant improvement in cardio-metabolic profile… read more here.

Keywords: obesity drugs; obesity; anti obesity; meta analysis ... See more keywords

Anti-obesity drugs for the gastroenterologist

Sign Up to like & get
recommendations! Published in 2025 at "Frontline Gastroenterology"

DOI: 10.1136/flgastro-2024-102995

Abstract: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasingly used in the management of diabetes mellitus and obesity and have become accessible to many through non-standard prescribing pathways. Studies are demonstrating a plethora of positive effects on… read more here.

Keywords: anti obesity; obesity; obesity drugs; gastroenterology ... See more keywords
Photo from wikipedia

Effects of anti-obesity drugs on cardiometabolic risk factors in pediatric population with obesity: a systematic review and meta-analysis of randomized controlled trials

Sign Up to like & get
recommendations! Published in 2025 at "International Journal of Adolescent Medicine and Health"

DOI: 10.1515/ijamh-2024-0196

Abstract: Abstract Following prospective registration (PROSPERO CRD42024564275), three databases (PubMed, SCOPUS, Web of Science) were searched for trials reporting the effects of anti-obesity drugs (AODs) (with placebo as control) on cardiometabolic risk factors in the pediatric… read more here.

Keywords: effects anti; anti obesity; obesity; risk ... See more keywords